3D Models Workshop – Nottingham 14th June 2017
Program
NB. Before each break
delegates will be provided with cards in which to write down any questions that
they wish to put to the speakers, these will then be discussed after the break by
the session chair and the speakers. At the end of this 15 minutes discussion
the audience will be invited to ask any additional questions.
For the short talks
questions will be taken immediately after the talk to make the format less
intimidating for less experienced speakers.
At the close of the
day there will be 30 minutes for open discussion to allow delegates and
speakers to interact and maximise their learning output from this workshop.
Proposed timetable
14th June
09:00 – 09:30 Registration
09:30 – 09:40 Introduction and Welcome (PO & AG)
09:40 – 10:25 Prof. Claudia Fichbach (Ithaca NY, USA) ÒTissue engineering with fabrication technologies to look at the role of microenvironmental conditions in tumourigenesisÓ.
10:25 -10:55 Dr Craig Murdoch (University of Sheffield) Development of tissue engineered models of oral dysplasia.
10:55 – 11:15 Coffee break
11:15 – 11:30 Discussion of previous talks (Chaired by Dr Neil Cross, Sheffield Hallam University)
11:30 – 12:00 Prof Anna Grabowska (University of Nottingham) Ò3D models using patient-derived xenografts for drug sensitivity screening – the importance of human stromal cellsÓ
12:00 – 12:30 Dr Penelope Ottewell (University of Sheffield) ÒClinically relevant 3D models of human breast cancer bone metastasisÓ.
12:30 – 13:00 2X 15 minute short talks (inc. questions) selected from abstracts (NB: travel bursaries will be paid to these speakers)
13:00 -14:00 Lunch and poster viewing
14:00; 14:15 Discussion of previous talks (Chaired by Dr Craig Murdoch, University of Sheffield)
14:15 - 14:45 Prof. Marilena Loizidou (UCL, London) Ò3D colorectal cancer models, efficiency of cholesterol liposomes and micelles as nanocarriersÓ.
14:45 – 15-45 4X 15 minute short talks (inc. questions) selected from abstracts (NB: travel bursaries will be paid to these speakers)
15:45 – 16:15 Coffee break
16:15 – 17:00 Dr Jos Jonkers (Netherlands Cancer Institute) ÒUse of genetically engineered mouse models and PDX to model breast cancer development and response to therapiesÓ.
16:45 – 17:15 Open floor discussion and closing remarks (delegates can ask questions from any of the speakers. (Chaired by Dr Penelope Ottewell, University of Sheffield and Prof Anna Grabowska, University of Nottingham)
Tumour Microenvironment Meeting